(Q40587349)

21 September 2017

1 reference

title

Castleman's disease in patients infected with HIV (English)

1 reference

21 September 2017

1 reference

L Aaron

1

1 reference

21 September 2017

O Lidove

2

1 reference

21 September 2017

J P Viard

3

1 reference

21 September 2017

D Troisvallet

4

1 reference

21 September 2017

C Piketty

5

1 reference

21 September 2017

D Vittecoq

6

1 reference

21 September 2017

D Zucman

7

1 reference

21 September 2017

O Blétry

8

1 reference

21 September 2017

B Dupont

9

1 reference

21 September 2017

language of work or name

French

0 references

publication date

1 February 2002

1 reference

Revue de Médecine Interne

21 September 2017

published in

1 reference

21 September 2017

volume

23

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

155-163

1 reference

Localized mediastinal lymphnode hyperplasia resembling thymoma

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Lymph node modification in patients with the acquired immunodeficiency syndrome (AIDS) or with AIDS related complex (ARC). A histological, immuno-histopathological and ultrastructural study of 45 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Kaposi's sarcoma herpesvirus-like DNA sequences in the saliva of individuals infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Resolution of membranoproliferative glomerulonephritis complicating angiofollicular lymph node hyperplasia (Castleman's disease)

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Plasmacellular Castleman's disease and POEMS syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

The Crow-Fukase syndrome: a study of 102 cases in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

An immunohistological and genotypic study of the plasma cell form of Castleman's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Multicentric Castleman's disease in association with a solitary plasmacytoma: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Molecular genetic, cytogenetic, and immunophenotypic analyses in Castleman's disease of the plasma cell type

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Biological and clinical aspects of interleukin 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Immunodeficiency and IL-6 production by peripheral blood monocytes in multicentric Castleman's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Giant lymph node hyperplasia (Castleman's disease) with spontaneous production of high levels of B-cell differentiation factor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Expression of interleukin-6 in Castleman's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

The role of human herpesvirus 8 and Epstein-Barr virus in the pathogenesis of giant lymph node hyperplasia (Castleman's disease).

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Tropism of human herpesvirus 8 for peripheral blood lymphocytes in patients with Castleman's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Transient angiolymphoid hyperplasia and Kaposi's sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Is interferon-a an active agent in Castleman's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Successful treatment of multicentric Castleman's disease in a patient with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Aggressive angiofollicular lymph node hyperplasia (Castleman's disease) treated with high dose melphalan and autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

2-Chloro-deoxyadenosine therapy for giant lymph node hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Retinoid antagonism of NF-IL6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Retinoic acid for treatment of multicentric Castleman's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

Multicentric giant follicular lymph node hyperplasia. Favorable response to radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2801%2900531-8

7 January 2021

10.1016/S0248-8663(01)00531-8

Identifiers

DOI

1 reference

release_i3lizz4vjfddxbxlpfjd2ui7ma

21 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/i3lizz4vjfddxbxlpfjd2ui7ma

24 November 2022

mapped directly with Wikidata item

1 reference